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31P-NMR spectra of newborn dog brains exhibit a prominent phosphomonoester (PME) peak (6.78 2 SD. 
0.05 ppm from phosphocreatine peak), similar to those of human neonates. Studies were undertaken to 
identify the chemical constituents of this peak. Brains of puppies were funnel frozen for methanol-HCl- 
perchloric acid extraction after in vivo 3*P-NMR spectra were taken. The ply of the major component of 
the PME region in the NMR spectrum ofextract was 5.4, corresponding to that of phosphorylethanolamine 
(PEt). Addition of PEt increased the major peak on the PME region over a wide range of pH, while addition 
of phosphorylcholine or ribose 5-phosphate yielded istinct peaks. We suggest that the major constituent 
of phosphomonoester peak of 31P-NMR spectra of newborn dog brain is phosphorylethanolamine. 
Biochemical mechanisms relevant to changes of phosphorylethanolamine during brain deveiopment are dis- 
cussed. 
31 P-NMR spectroscopy in vivo Phosphorylethanolamine Brain development Phosphomonoester 
Sugar phosphate 
1. INTRODUCTION observed similar high levels of PMEs in tumor 
tissues, particularily in neuroblastoma [ ]. 
The presence of phosphomonoesters (PME) was The identification of compounds which con- 
discovered in tumor tissues as early as 1937 [I]. In tribute to the PME peak of in vivo 31P-NMR spec- 
1939 these compounds were found in the smal1 in- tra is difficult, since “P resonance -peaks of 
testines of rabbits and pigs [2]. Ten years later numerous phosphomonoesters are reasonably 
authors in j3] reported the presence of phosphoryl- close [9-II] and therefore overlap. It was sug- 
ethanolamine (PEt) in 23 organs and various gested [5] that ribose 5phosphate was the major 
malignant tumors of rat. Then it was shown [4] component of this peak in the 31P-NMR spectra of 
that the PEt concentration decreased during the human neonate brain. Among the PMEs giving 
postnatal development of mammalian brain. This 
observation lay fallow until 3’P-NMR studies, par- 
resonance peaks in this region are sugar phos- 
phates such as glucose 6-phosphate, ribulose 
ticularly [5,6], called attention to the existence of 
an intense PME peak in the in vivo 31P-NMR spec- 
5-phosphate, xylulose S-phosphate, fructose 1,6- 
diphosphate, erythrose 4-P, besides ribose 5-phos- 
tra of human neonate brains. The intensity of the phate; however, the total concentration of these 
PME peak appears somewhat diminished in an compounds is generally not more than 0.5-0.6 mM 
&year-old child [7] and decreases further in adult 112-141 in brain. Other PMEs such as PEt and 
humans (J.S. Leigh and C.H. Barlow, Biophysics phospho~lcholine also have resonance peaks in 
Today (July 22, 1983) Authors in [8,9] have also this region, and their concentration ranges from 
Phospholipid synthesis 
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2-4 mM depending on species and age 1151. 
Therefore, our hypothesis was that one of these 
compounds could be the major contributor to this 
resonance peak. Preliminary experiments show 
that the in vivo 31P-NMR spectra of brains of 
human neonates and newborn dogs are similar. 
Therefore, puppies can serve as a convenient 
model for studying the chemical nature of the 
PME region. It will be demonstrated that the 
major constituent of the PME peak of “P-NMR 
spectra brains of newborn dog is PEt. 
2. MATERIALS AND METHODS 
2.1. in vivo “P-NMR of puppy brain 
Experiments were carried out on 17-day-old 
puppies, anaesthetized with Inovar-Vet (0.2 ml/ 
kg). In vivo ““P-NMR spectra were taken on a 1.5 
T 12 in diameter bore Oxford magnet equipped 
with a Phosphoenergetics pectrometer. A two- 
turn 3.8 cm diameter copper coil was tuned and 
matched to 24.5 MHz and placed on the skull after 
the skin and muscle were removed. Acquisition 
parameters were nominal 90” flip angle; repetition 
rate 0.25 Hz, total observation time 16 min. 
Chemical shifts are reported as ppm from PCr. 
2.2, Preparation of acid extracts of brain 
Brains of puppies (n= 3) were funnel frozen 
with liquid nitrogen [14] following the in vivo 
NMR spectrum. The brains were carefully re- 
moved from the cerebral cavity and pulverized at 
- 195°C in liquid nitrogen. Methanol-HCl-PCA 
(perchloric acid) extraction was performed as 
described in (161. The extract was passed through 
a Chelex column to lower the concentration of 
alkaline earth and transition metal ions. The ex- 
tract was then lyophilized and dissolved in 2.5 ml 
of 20% D20 before NMR analysis. 
2.3. 3’P-NA4R analysis of extracts 
3’P-NMR spectra were obtained using a Bruker 
WH-360 NMR spectrometer operating at 145 MHz 
for phosphorus. Acquisition parameters were: 
pulse width, 45 pus; repetition rate, 0.4 Hz; sweep 
width, 5000 Hz; acquisition time, 1.6 s; line broad- 
ening, 0.5 Hz. Chemical shifts are reported as ppm 
from 85% orthophosphoric acid using glycerol- 
phosphorylcholine (S = 0.49) as an internal stan- 
dard. PCr is -2.39 ppm from orthophosphoric 
acid. 
2.4. ~dentifi~ati~~ of the resonance peaks 
Identification of the major PME resonance peak 
in brain extracts was made according to the follow- 
ing protocol: (i) NMR analysis using a library of 
resonance peak positions according to the existing 
data in the literature [9- 11,171. (ii) Determination 
of the pH dependence of the chemical resonance 
shift in the extract for the peaks of interest and 
determination of the ply. (iii) Addition of known 
phosphate compound to the extract to determine 
whether the resonance peak originating from the 
added substance is superimposed on the peak of in- 
terest at several different pH values. 
Further evidence that the compound identified 
can be attributed to the peak of interest in vivo was 
provided by pH titrations of possible candidates in 
a solution resembling the composition of whole 
brain. The concentration of the constituents of the 
model solution were as follows: NaH2C03, lo-15 
mM; NazHPO.+, IO-15 mM; MgClz, 8 mM; KC& 
90 mM; ATP, 5 mM; PCr, 10 mM. The pH- 
dependent chemical shift curve of the following 
substances were determined: ribose j-phosphate, 
glucose 6-phosphate, PEt, PCh and Pi. The pH of 
the solution was changed by adding 5 N KOH or 
4 N HCI. “P-NMR spectra were taken at 37°C on 
a Bruker 200 CXP NMR spectrometer operating at 
80.98 MHz for phosphorus and 200 MHz for pro- 
ton. Acquisition parameters were: 45” flip angle; 
repetition rate, 0.4 Hz; 60 repetitions; sweep 
width, 5000 Hz. 
3. RESULTS AND DISCUSSION 
Fig.1 is a typical in vivo “P-NMR spectrum of 
a puppy brain illustrating its close resemblance to 
spectra of human neonates [5,6]. The chemical 
shift of the prominent phosphomonoester peak 
was 6.78~t SD 0.05 ppm, that of the P, was 
5.05 aSD 0.11 ppm from PCr (n=5). The 31P- 
NMR spectra of puppy brain showed a PME/PCr 
ratio of 1.99 f SD 0.25 and PME/ATP ratio of 
0.95 f SD 0.23. 3’P-NMR spectra of adult dog 
brain also exhibit a prominent PME peak (fig.2, 
table 1) equivalent o approx. 2 mM concentration. 
The results of the pH dependence of the chemi- 
cal shifts of glucose &phosphate, ribose 5-phos- 
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Fig.1. ‘iP-NMR spectrum of a 17-day-old puppy brain. 
PME, phosphomonoesters; P,, inorganic phosphate; 
PD, phosphodiesters; PCr, phosphocreatine; uNTP, 
,&NTP, yNTP, crS,y, phosphate of nucleotide triphos- 
phates. The fitted spectrum and peaks were determined 
as in 181. The fitted peaks are shifted down. 
phate, PEt, PCh and Pi in the model solution for 
whole brain (fig.3) show that, when the chemical 
shift of Pi from PCr is 5.00 ppm, that of PEt is 
6.8, which is similar to the chemical shift of the 
PME peak in the in vivo spectrum. However, at 
this pH, glucose 6-phosphate would be downfield 
while ribose S-phosphate and PCh are upfield of 
PEt (fig.3). Fig.4 shows a spectrum of a PCA ex- 
tract of puppy brain, the in vivo spectrum of which 
is shown in fig.1. The dominant peak in the PME 
region is 4.5 ppm from 85% orthophosphoric acid 
20 mm SCil” 
- Orlpinal 
---- FItted 
Fitted Peaka 
Fig-Z. 3’P-NMR spectrum of adult dog brain. Peak iden- 
tification: see fig.1. Spectra were taken on a Phospho- 
energetics 12 in NMR system using a 4-cm diameter 
single turn surface coil. Acquisition parameters repeti- 
tion rate, 0.25 Hz; flip angle, nominal 90”; total obser- 
vation time 20 min. 
Table 1 
Relative peak areas from in vivo “P-NMR spectra of 
brains of various species 
PME PME PME PCr PCr __ __ -_- __ I__ 
P, PCr ATP PI ATP 
I Newborn dog 2.21 1.99 0.95 1.13 0.48 
II Human neonate 2.78 2.14 i.5 1.3 0.7a 
III Adult dog 1.86 0.74 0.80 2.71 1.14b 
IV Adult gerbil I.14 0.54 1.00 2.21 1.75c 
“I61 
bAlso I181 
‘I191 
at pH 7.5. The pH titration of this resonance peak 
(fig.5) in the extract resulted in a p& of 5.4 which 
corresponds closely to the p& of PEt [9,11)* Addi- 
tion of PEt to the extract resulted in peak superim- 
posed on this peak at pH 7.5 (fig.61 and over a 
wide range of pH values (fig.5). Addition of ribose 
S-phosphate to this sample resulted in a superim- 
posed peak at 4.5 ppm at pH 7.5; however, at pH 
6.6 the ribose 5-phosphate peak shifted to 3.7 ppm 
while the composite peaks of added PEt and the 
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Fig.3. Dependence of chemical shifts of PEt, phosphor- 
yicholine (PCh), ribose S-phosphate (RSP), glucose 
6phosphate (G6P) and inorganic phosphate (Pi) on pH. 
Composition of medium is described in section 2. 
Chemical shift expressed relative to both orthophosphic 
acid (right scale) and PCr (left scale), respectively. 
Measurements were made at 37°C. 
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Fig.4. “P-NMR spectrum of puppy brain extract. This 
spectrum is a result of 3000 accumulations (conditions in 
text). Assignment of peaks in the PME region made in 
accordance with experimental results. PEt, phosphoryl- 
ethanolamine; PCh, phosporylcholine; GPC, glycerol- 
phosphorylcholine; GPE, glycerolphosphorylethanol- 
amine. 
major PME peak in the brain extract remained 
superimposed at 4.2 ppm. Addition of phosphoryl- 
choline resulted in peak upfield from the peaks of 
interest at wide range of pH values (fig.5,6). Based 
on the above data, we concluded that the peak at 
4.5 ppm in the brain extract arises from PEt. Since 
at the physiological intracellular pH, as deter- 
mined by the chemical shift of Pi, the chemical 
shift of PEt in our model solution (fig.3) and in 
vivo (fig. I), is practically the same, we suggest hat 
the prominent peak in PME region of “P-NMR 
spectra of in vivo puppy brain originates mainly 
from PEt. Furthermore, because the chemical shift 
of the PME peaks in newborn infants is 6.72 + SD 
0.11 [5], we suggest he major component of this 
peak is PEt. The chemical shift of PME peak on 
dog brains is 6.71& SD 0.09 (that of Pi = 4.84 + SD 
0.11) (see also [IB]) and on gerbil brain it is 
6.76kSD 0.02 (Pi=4.9*SD 0.04) ppm [19]; 
therefore, it seems probable that the PEt of these 
species also contributes to the PME peak. 
The fact that PME peak is less prominent in 
adult dogs [18] (fig.2) than in puppies corresponds 
to the well established fact that PEt concentration 
EXTRACT pH TITRATION 
Puppy Brain 
PEt 
PCh 
O-Added PEt 
6.0 
PH 
7.0 8.0 
Fig.5. pH dependence of chemical shift of PEt (ti) 
and PCh (O--O) in the puppy brain extract. pK, values 
were determined to be 5.4 and 5.7 for PEt and PCh, 
respectively. (o---o) added PEt. 
of the brain decreases during maturation in dogs 
[20]. The exact biochemical mechanism explaining 
the changes in concentration of PEt is not well 
described in the literature. Experimental data sug- 
gest that the cytidyltransferase reaction is the rate 
limiting step [21] in the enzymatic reactions in- 
volved in the de novo synthesis of phosphatidyl- 
ethanolamine, although the ethanolamine-kinase is 
also in disequilibrium [22]. Consequently, an in- 
crease in the rate of the cytidyltransferase reaction 
should lead to a decrease of PEt and an increase in 
phosphatidylethanolamine. Indirect evidence sug- 
gests that this hypothesis holds true in vivo. The 
synthesis of phosphatidylcholine (lecithin) is 
catalysed by similar enzymes and involves ana- 
logous steps to that of phosphatidylethanolamine 
synthesis. The kinase reaction varies little, while 
the activity of cytidyltransferase and phosphoryl- 
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Fig.6. PME region of puppy brain extract before and after addition of known compounds. A. Before additions, pH 
7.51. B. With added PEt, pH 7.54. C. With added PCh, pH 7.56. D. With added R-5-P, pH 7.58. E. Same as D except 
at pH 6.58 (with PCh). 
choline transferase increases in developing brain 
post partum [23]. Also, the phosphatidylethanol- 
amine concentration increases in brain during 
maturation [24]. This pattern corresponds to the 
one suggested above. These results show that with 
careful analysis of 31P-NMR spectra of brain, in 
vivo “P-NMR could be useful in studying 
metabolism of phosphoglycerides and the matura- 
tion of the brain. 
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